S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY

Detalles Bibliográficos
Autores principales: Houot, Roch, Bachy, Emmanuel, Cartron, Guillaume, Gros, Francois-Xavier, Morschhauser, Franck, Oberic, Lucie, Gastinne, Thomas, Feugier, Pierre, Duléry, Rémy, Thieblemont, Catherine, Joris, Magalie, Jardin, Fabrice, Choquet, Sylvain, Casasnovas, Rene Olivier, Brisou, Gabriel, Cheminant, Morgane, Bay, Jacques Olivier, Llamas, Francisco, Menard, Cedric, Tarte, Karin, Delfau-Larue, Marie-Helene, Itti, Emmanuel, Bailly, Clément, Al Tabaa, Yassine, Laurent, Camille, Lemonnier, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428382/
http://dx.doi.org/10.1097/01.HS9.0000967844.56791.ba

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428382/
http://dx.doi.org/10.1097/01.HS9.0000967844.56791.ba

Ejemplares similares